Go to the list of all blogs
published in Blogs
Apr 29, 2026
Ichor Holdings (ICHR): +58% Gain in 30 Days on Semiconductor Momentum

Ichor Holdings (ICHR): +58% Gain in 30 Days on Semiconductor Momentum

Key Takeaways

  • ICHR surged +58% over the past 30 days, driven by strong momentum in the semiconductor equipment sector and analyst upgrades.
  • The stock climbed +99% over the past quarter, reflecting a broader recovery in wafer fabrication equipment (WFE) spending and AI-related demand.
  • Key factors include robust semiconductor industry tailwinds, positive preliminary financial outlooks, and high institutional ownership exceeding 100% of shares outstanding.
  • Recent volatility featured a steady upward trend with a peak near 52-week highs, supported by sector performance outpacing broader markets.
  • Upcoming Q1 2026 earnings could influence near-term direction amid ongoing chip demand growth.

Understanding Ichor Holdings (ICHR) and Its Market Position

Ichor Holdings, Ltd. (ICHR) provides critical fluid delivery subsystems and precision components for semiconductor capital equipment. The company specializes in parts essential for manufacturing processes such as etch, deposition, and cleaning, supplying major original equipment manufacturers (OEMs) in the semiconductor space. Operating firmly in the technology sector—particularly semiconductor equipment and materials—ICHR delivers focused exposure to the cyclical semiconductor supply chain.

Unlike diversified ETFs, ICHR generates revenue mainly from gas, chemical delivery, and machined components for semi OEMs like AMAT and LRCX. This targeted reliance on WFE demand goes a long way in explaining its recent price action, as increases in chip production capacity directly enhance its order book and revenue prospects.

ICHR Price Performance: 30 Days Versus the Quarter

In the last 30 days, Ichor Holdings, Ltd. (ICHR) advanced +58%, climbing from about $42 to $66.54. The move was trend-based with moderate volatility, showing steady gains through April and peaking above $70 before a slight retreat. I also checked this using Tickeron’s AI Screener to compare it against peers in the sector.

Over the quarter, ICHR posted a +99% gain, rising from roughly $33 to current levels. Momentum built strongly from early-year lows during the sector recovery, with higher volume on up days and less sideways action.

Drivers Behind ICHR's 30-Day Surge

The +58% rise in ICHR over the past 30 days reflects growing investor confidence in semiconductor equipment. Standout catalysts were analyst upgrades, including Stifel's Buy rating with a $55 target in March, alongside industry tailwinds from elevated WFE spending tied to AI chip demand.

Peers in semiconductors also advanced, boosting ICHR as its fluid delivery systems tie directly to rising capital equipment orders. Positive sentiment around preliminary Q4 2025 results and Q1 2026 guidance of at least $240 million in revenue added fuel. With institutional ownership above 100%, the rally held firm without notable selling pressure. The stock's beta of 1.67 underscores its link to sector moves, tying OEM capex expansion to ICHR's appreciation.

Factors Fueling ICHR's Quarterly Performance

ICHR's +99% quarterly advance came from a semiconductor rebound, with global sales expected to reach record highs in 2026 on AI and data center growth. Broader trends like WFE recovery after the downturn and projections for $1.3 trillion in sector revenue by 2026 built sustained support.

Macro tailwinds from ongoing tech expansion overshadowed earlier inventory issues. Institutional buying, with BlackRock and Vanguard holding over 24% combined, bolstered the uptrend. ICHR outpaced the semiconductor equipment industry, which posted solid but less dramatic gains, thanks to demand for its specialized components from top OEMs.

Tools I Use: Tickeron’s AI Screener

One tool I find invaluable for dissecting stocks like ICHR is Tickeron’s AI Screener. This AI-powered platform lets me scan thousands of stocks and ETFs using filters for technical patterns, fundamentals, trends, volatility, and AI signals—such as industry, market cap, indicators, price patterns, and performance metrics. It uncovers trade ideas, breakouts, and opportunities far faster than manual reviews, helping refine my strategy. From what I see, it's a practical way to stay ahead in this fast-moving sector.

What to Watch Next for ICHR Investors

Keep an eye on the semiconductor outlook, especially WFE trends and AI infrastructure spending. Q1 2026 earnings on May 4 will shed light on revenue and margins. Monitor key OEM customers like AMAT and LRCX for demand cues. Broader factors include interest rates affecting tech capex and global chip supply dynamics. Risks center on cyclical slowdowns or order delays, while upsides may come from analyst updates or sector M&A.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.

Related Ticker: ICHR

ICHR in downward trend: 10-day moving average broke below 50-day moving average on July 29, 2026

The 10-day moving average for ICHR crossed bearishly below the 50-day moving average on July 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICHR as a result. In of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ICHR turned negative on August 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

ICHR moved below its 50-day moving average on July 27, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ICHR entered a downward trend on August 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ICHR's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ICHR advanced for three days, in of 323 cases, the price rose further within the following month. The odds of a continued upward trend are .

ICHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.605) is normal, around the industry mean (8.019). P/E Ratio (0.000) is within average values for comparable stocks, (159.406). ICHR's Projected Growth (PEG Ratio) (0.544) is slightly lower than the industry average of (1.475). ICHR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.006). P/S Ratio (2.060) is also within normal values, averaging (33.263).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ICHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 65, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 63.51B. The market cap for tickers in the group ranges from 555.66K to 676.06B. ASML holds the highest valuation in this group at 676.06B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was -10%. For the same Industry, the average monthly price growth was 70%, and the average quarterly price growth was 74%. ACMR experienced the highest price growth at -1%, while SMTK experienced the biggest fall at -98%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -12%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -59%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 34
Price Growth Rating: 48
SMR Rating: 73
Profit Risk Rating: 64
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
ICHR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a holding company whose subsidiary manufactures gas and chemical delivery systems for semiconductor process equipment

Industry ElectronicProductionEquipment

Profile
Details
Industry
Semiconductors
Address
3185 Laurelview Court
Phone
+1 510 897-5200
Employees
2448
Web
https://www.ichorsystems.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.